Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study

The Photobiomodulation therapy could have positive effects on quality of life and oral health in head and neck cancer survivors post-radiotherapy. The improvement in quality of life will be maintained after a follow-up period.

Trial Details

NCT ID
NCT05106608
Phase
NA
Sponsor
Universidad de Granada
Status
RECRUITING
Cancer Type
Salivary Gland Head and Neck Cancer
Interventions
  • Energy density photobiomodulation (7.5)
  • Energy density photobiomodulation (3)
  • Sham placebo
Locations (sample)
  • Granada, Granada, Spain|37.18817,-3.60667

Key Eligibility Criteria

  • men or women aged 18 years or older and were diagnosed with HNC.
  • chronic xerostomia.
  • received RT in the parotid, submandibular and/or sublingual salivary glands.
  • grade 3 oral dryness according to the Common Terminology Criteria for Adverse Events version 5.0 (CTCAE).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Salivary Gland Head and Neck Cancer Trials on Trialify →